Belpointe Asset Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-475
| Closed | -$14.5K | – | 860 |
|
2023
Q1 | $14.5K | Sell |
475
-2,350
| -83% | -$72K | ﹤0.01% | 2501 |
|
2022
Q4 | $110K | Sell |
2,825
-50
| -2% | -$1.96K | 0.01% | 1187 |
|
2022
Q3 | $137K | Buy |
+2,875
| New | +$137K | 0.01% | 999 |
|
2022
Q2 | – | Sell |
-2,400
| Closed | -$138K | – | 1142 |
|
2022
Q1 | $138K | Sell |
2,400
-35
| -1% | -$2.01K | 0.01% | 1077 |
|
2021
Q4 | $194K | Hold |
2,435
| – | – | 0.01% | 912 |
|
2021
Q3 | $212K | Buy |
2,435
+8
| +0.3% | +$697 | 0.01% | 829 |
|
2021
Q2 | $312K | Hold |
2,427
| – | – | 0.02% | 652 |
|
2021
Q1 | $194K | Buy |
2,427
+68
| +3% | +$5.44K | 0.02% | 762 |
|
2020
Q4 | $193K | Buy |
+2,359
| New | +$193K | 0.02% | 704 |
|